Breast cancer treatment, such as chemotherapy and endocrine therapy, can cause earlier and more sudden menopausal symptoms. Genitourinary syndrome of menopause (GSM) is one of the most bothersome side effects of breast cancer treatment, resulting in sexual dysfunction and impaired quality of life. GSM includes genital, urinary, and sexual symptoms. However, alleviating symptoms of GSM for breast cancer survivors may be challenging due to ineffectiveness, contraindications, and low adherence to treatment. The most recent data show the feasibility and safety of vaginal laser to treat GSM for breast cancer survivors. This narrative review provides the aspects of GSM in breast cancer patients, putting the focus on the efficacy and safety of vag...
Genitourinary syndrome of menopause (GSM) is a highly prevalent, not self-limiting condition display...
Gynecologist and plastic surgeons pioneered the application of lasers in medicine and surgery almost...
Menopause represents an endocrine challenge to urogenital health, as oestrogens deprivation and andr...
Introduction Genitourinary syndrome of menopause (GSM) is caused by hypo-estrogenism, resulting i...
Adjuvant chemotherapy and endocrine therapy can induce early iatrogenic menopause or worsen pre-exis...
There is increasing attention about managing the adverse effects of adjuvant therapy (Chemotherapy a...
To assess the effects of vaginal erbium laser treatment on the vaginal health and sexual function of...
Laser therapy has been proposed to improve the symptoms of genitourinary syndrome of menopause (GSM)...
Context: Genitourinary Syndrome of Menopause (GSM) is an umbrella term covering various symptoms of ...
Background: Breast cancer (BC) is the most common female cancer worldwide. Menopausal symptoms are a...
Introduction: One of the most common adverse events reported by gynecological cancer survivors with ...
PurposeThe objectives of this study were to evaluate the feasibility and efficacy of fractional CO2 ...
Importance: Genitourinary syndrome of menopause can be treated with vaginal estrogen therapy. Howeve...
Vaginal birth trauma is the leading cause of stress urinary incontinence (SUI) in women. Also, the p...
OBJECTIVES: Breast cancer is one of the most common malignancies in women. Hormonal treatment and c...
Genitourinary syndrome of menopause (GSM) is a highly prevalent, not self-limiting condition display...
Gynecologist and plastic surgeons pioneered the application of lasers in medicine and surgery almost...
Menopause represents an endocrine challenge to urogenital health, as oestrogens deprivation and andr...
Introduction Genitourinary syndrome of menopause (GSM) is caused by hypo-estrogenism, resulting i...
Adjuvant chemotherapy and endocrine therapy can induce early iatrogenic menopause or worsen pre-exis...
There is increasing attention about managing the adverse effects of adjuvant therapy (Chemotherapy a...
To assess the effects of vaginal erbium laser treatment on the vaginal health and sexual function of...
Laser therapy has been proposed to improve the symptoms of genitourinary syndrome of menopause (GSM)...
Context: Genitourinary Syndrome of Menopause (GSM) is an umbrella term covering various symptoms of ...
Background: Breast cancer (BC) is the most common female cancer worldwide. Menopausal symptoms are a...
Introduction: One of the most common adverse events reported by gynecological cancer survivors with ...
PurposeThe objectives of this study were to evaluate the feasibility and efficacy of fractional CO2 ...
Importance: Genitourinary syndrome of menopause can be treated with vaginal estrogen therapy. Howeve...
Vaginal birth trauma is the leading cause of stress urinary incontinence (SUI) in women. Also, the p...
OBJECTIVES: Breast cancer is one of the most common malignancies in women. Hormonal treatment and c...
Genitourinary syndrome of menopause (GSM) is a highly prevalent, not self-limiting condition display...
Gynecologist and plastic surgeons pioneered the application of lasers in medicine and surgery almost...
Menopause represents an endocrine challenge to urogenital health, as oestrogens deprivation and andr...